CorVent Earns FDA Emergency Clearance for Multi-Patient Ventilator System
CorVent has been given an Emergency Use Authorization for its RESPOND-19 ventilator device, a system designed in response to the COVID-19 pandemic that can be used for multiple hospitalized patients.
The system provides primary critical care support and is designed to rapidly expand ventilation capacity in hospitals for patients with acute respiratory distress syndrome.
The plug-and-play ventilator is equipped with multi-stage antiviral filters to provide infection control for patients and healthcare providers, and can be stored long-term without maintenance. The company anticipates receiving CE mark certification for the device early next year.